Your browser doesn't support javascript.
loading
Comparison of clinical prediction rules for ruling out cirrhosis in nonalcoholic fatty liver disease (NAFLD).
Brandman, Danielle; Boyle, Marie; McPherson, Stuart; Van Natta, Mark L; Sanyal, Arun J; Kowdley, Kris; Neuschwander-Tetri, Brent; Chalasani, Naga; Abdelmalek, Manal F; Terrault, Norah A; McCullough, Art; Bettencourt, Ricki; Caussy, Cyrielle; Kleiner, David E; Behling, Cynthia; Tonascia, James; Anstee, Quentin M; Loomba, Rohit.
Afiliación
  • Brandman D; Division of Gastroenterology, Department of Medicine, University of California San Francisco, San Francisco, California, USA.
  • Boyle M; Translational & Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
  • McPherson S; Newcastle NIHR Biomedical Research Centre, Newcastle upon Tyne Hospitals NHS Trust, Newcastle upon Tyne, UK.
  • Van Natta ML; Translational & Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
  • Sanyal AJ; Newcastle NIHR Biomedical Research Centre, Newcastle upon Tyne Hospitals NHS Trust, Newcastle upon Tyne, UK.
  • Kowdley K; John Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Neuschwander-Tetri B; Department of Internal Medicine, Medical College of Virginia, Richmond, Virginia, USA.
  • Chalasani N; Swedish Medical Group, Seattle, Washington, USA.
  • Abdelmalek MF; Division of Gastroenterology and Hepatology, Department of Medicine, Saint Louis University, Saint Louis, Missouri, USA.
  • Terrault NA; Division of Gastroenterology and Hepatology, Department of Medicine, Indiana University, Indianapolis, Indiana, USA.
  • McCullough A; Division of Gastroenterology, Hepatology, and Nutrition, Duke University, Durham, North Carolina, USA.
  • Bettencourt R; Division of Gastroenterology and Liver, Keck Medicine, University of Southern California, Los Angeles, California, USA.
  • Caussy C; Department of Gastroenterology and Hepatology, Cleveland Clinic, Cleveland, Ohio, USA.
  • Kleiner DE; NAFLD Research Center, Department of Medicine, University of California San Diego, San Diego, California, USA.
  • Behling C; NAFLD Research Center, Department of Medicine, University of California San Diego, San Diego, California, USA.
  • Tonascia J; Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Anstee QM; Analytic Pathology Medical Group, Sharp Memorial Hospital, San Diego, California, USA.
  • Loomba R; John Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Aliment Pharmacol Ther ; 55(11): 1441-1451, 2022 06.
Article en En | MEDLINE | ID: mdl-35302256
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedad del Hígado Graso no Alcohólico Tipo de estudio: Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans Idioma: En Revista: Aliment Pharmacol Ther Asunto de la revista: FARMACOLOGIA / GASTROENTEROLOGIA / TERAPIA POR MEDICAMENTOS Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedad del Hígado Graso no Alcohólico Tipo de estudio: Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans Idioma: En Revista: Aliment Pharmacol Ther Asunto de la revista: FARMACOLOGIA / GASTROENTEROLOGIA / TERAPIA POR MEDICAMENTOS Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos